PL2411503T3 - Salmonella enterica prezentująca n-glikan z c. jejuni lub jego pochodne - Google Patents
Salmonella enterica prezentująca n-glikan z c. jejuni lub jego pochodneInfo
- Publication number
- PL2411503T3 PL2411503T3 PL10715098T PL10715098T PL2411503T3 PL 2411503 T3 PL2411503 T3 PL 2411503T3 PL 10715098 T PL10715098 T PL 10715098T PL 10715098 T PL10715098 T PL 10715098T PL 2411503 T3 PL2411503 T3 PL 2411503T3
- Authority
- PL
- Poland
- Prior art keywords
- jejuni
- glycan
- presenting
- derivatives
- salmonella enterica
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K2039/106—Vibrio; Campylobacter; Not used, see subgroups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Fodder In General (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09004445 | 2009-03-27 | ||
PCT/EP2010/001884 WO2010108682A1 (en) | 2009-03-27 | 2010-03-25 | Salmonella enterica presenting c. jejuni n-glycan or derivatives thereof |
EP10715098.9A EP2411503B1 (en) | 2009-03-27 | 2010-03-25 | Salmonella enterica presenting c. jejuni n-glycan or derivatives thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2411503T3 true PL2411503T3 (pl) | 2018-01-31 |
Family
ID=42199060
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL10715098T PL2411503T3 (pl) | 2009-03-27 | 2010-03-25 | Salmonella enterica prezentująca n-glikan z c. jejuni lub jego pochodne |
Country Status (14)
Country | Link |
---|---|
US (2) | US9309493B2 (pl) |
EP (1) | EP2411503B1 (pl) |
JP (1) | JP5568626B2 (pl) |
KR (1) | KR101395431B1 (pl) |
CN (1) | CN102365359B (pl) |
BR (1) | BRPI1010283B8 (pl) |
CA (1) | CA2757224C (pl) |
ES (1) | ES2646320T3 (pl) |
IL (1) | IL215239A (pl) |
MX (1) | MX2011009791A (pl) |
PL (1) | PL2411503T3 (pl) |
PT (1) | PT2411503T (pl) |
RU (1) | RU2507253C2 (pl) |
WO (1) | WO2010108682A1 (pl) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2501406B8 (en) | 2009-11-19 | 2018-01-24 | GlaxoSmithKline Biologicals S.A. | Biosynthetic system that produces immunogenic polysaccharides in prokaryotic cells |
EP2753353A1 (en) * | 2011-09-06 | 2014-07-16 | Glycovaxyn AG | Bioconjugate vaccines made in prokaryotic cells |
WO2013159234A1 (en) | 2012-04-27 | 2013-10-31 | The Governors Of The University Of Alberta | Glycoengineered outer membrane vesicles and use thereof as vaccines |
US10258680B2 (en) | 2013-04-05 | 2019-04-16 | The Governors Of The University Of Alberta | Campylobacter vaccine |
CN103740632B (zh) * | 2014-01-22 | 2016-02-10 | 山东大学 | 一株重组大肠杆菌及其在制备抗o157:h7的n-糖蛋白疫苗中的应用 |
WO2018140717A1 (en) | 2017-01-27 | 2018-08-02 | University Of Florida Research Foundation Incorporated | A food safety vaccine to control salmonella enterica and reduce campylobacter in poultry |
AU2018235129A1 (en) | 2017-03-15 | 2019-10-24 | London School Of Hygiene And Tropical Medicine | Whole cell vaccines |
PE20171768A1 (es) * | 2017-06-12 | 2017-12-21 | Farm Veterinarios S A C | Obtencion de una salmonela enteritidis tipo rugosa y sus modificaciones geneticas para uso como vacuna aviar |
BR112020012553A2 (pt) * | 2017-12-19 | 2020-11-24 | The Governors Of The University Of Alberta | glicanos de superfície de clostridium perfringens e usos dos mesmos |
US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6399074B1 (en) | 1998-07-24 | 2002-06-04 | Megan Health, Inc. | Live attenuated salmonella vaccines to control avian pathogens |
AP2368A (en) * | 2001-05-03 | 2012-02-27 | Fit Biotech Oyj Plc | Novel expression vectors and uses thereof. |
CA2494223C (en) * | 2002-08-01 | 2012-10-02 | National Research Council Of Canada | Campylobacter glycans and glycopeptides |
RU2237089C2 (ru) * | 2002-10-31 | 2004-09-27 | Государственный научный центр вирусологии и биотехнологии "Вектор" | Рекомбинантный аттенуированный штамм бактерий salmonella enteriditis е-23/pgex-2t-tbi как кандидат для конструирования живой вакцины против вируса иммунодефицита человека |
PL1622648T3 (pl) * | 2003-03-24 | 2010-11-30 | Scripps Research Inst | Szczepionki DNA przeciwko wzrostowi nowotworów i sposoby ich stosowania |
RU2248396C2 (ru) * | 2003-04-17 | 2005-03-20 | Государственный научный центр вирусологии и биотехнологии "Вектор" | Рекомбинантная плазмидная днк pcdna-tci, обеспечивающая экспрессию искусственного гена tci в клетках эукариот, и рекомбинантный аттенуированный штамм бактерий salmonella enteritidis e-23/pcdna-tci как кандидат для конструирования живой днк-вакцины против вируса иммунодефицита человека |
EP1655370A1 (en) * | 2004-11-05 | 2006-05-10 | Gesellschaft für Biotechnologische Forschung | Bacterial vector |
ES2535084T3 (es) * | 2005-05-11 | 2015-05-05 | Eth Zurich | Proteínas N-glicosiladas recombinantes procedentes de células procariotas |
JP5044754B2 (ja) | 2005-09-21 | 2012-10-10 | アメリカ合衆国 | カンピロバクター・ジェジュニに対するワクチン成分として使用される免疫原莢膜組成物 |
DE102008012452A1 (de) * | 2008-03-04 | 2009-09-10 | Tridonicatco Gmbh & Co. Kg | Schaltung zum Beheizen und Überwachen der Heizwendeln mindestens einer mit einem elektronischen Vorschaltgerät betriebenen Gasentladungslampe auf Wendelbruch |
-
2010
- 2010-03-25 US US13/254,232 patent/US9309493B2/en active Active
- 2010-03-25 PL PL10715098T patent/PL2411503T3/pl unknown
- 2010-03-25 ES ES10715098.9T patent/ES2646320T3/es active Active
- 2010-03-25 KR KR1020117021982A patent/KR101395431B1/ko active IP Right Grant
- 2010-03-25 MX MX2011009791A patent/MX2011009791A/es active IP Right Grant
- 2010-03-25 CN CN201080015941.2A patent/CN102365359B/zh active Active
- 2010-03-25 PT PT107150989T patent/PT2411503T/pt unknown
- 2010-03-25 CA CA2757224A patent/CA2757224C/en active Active
- 2010-03-25 JP JP2012501188A patent/JP5568626B2/ja active Active
- 2010-03-25 BR BRPI1010283A patent/BRPI1010283B8/pt active IP Right Grant
- 2010-03-25 WO PCT/EP2010/001884 patent/WO2010108682A1/en active Application Filing
- 2010-03-25 EP EP10715098.9A patent/EP2411503B1/en active Active
- 2010-03-25 RU RU2011143381/10A patent/RU2507253C2/ru active
-
2011
- 2011-09-19 IL IL215239A patent/IL215239A/en active IP Right Grant
-
2016
- 2016-04-08 US US15/094,537 patent/US9764021B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
IL215239A (en) | 2016-02-29 |
CA2757224A1 (en) | 2010-09-30 |
PT2411503T (pt) | 2017-11-15 |
KR20110127714A (ko) | 2011-11-25 |
BRPI1010283B8 (pt) | 2021-05-25 |
BRPI1010283A2 (pt) | 2016-10-11 |
IL215239A0 (en) | 2011-12-29 |
JP2012521747A (ja) | 2012-09-20 |
JP5568626B2 (ja) | 2014-08-06 |
US20160213770A1 (en) | 2016-07-28 |
CA2757224C (en) | 2016-12-06 |
CN102365359A (zh) | 2012-02-29 |
WO2010108682A1 (en) | 2010-09-30 |
KR101395431B1 (ko) | 2014-05-14 |
RU2507253C2 (ru) | 2014-02-20 |
BRPI1010283B1 (pt) | 2021-04-06 |
CN102365359B (zh) | 2014-10-29 |
EP2411503A1 (en) | 2012-02-01 |
US20120100177A1 (en) | 2012-04-26 |
RU2011143381A (ru) | 2013-05-10 |
MX2011009791A (es) | 2011-10-17 |
US9764021B2 (en) | 2017-09-19 |
ES2646320T3 (es) | 2017-12-13 |
EP2411503B1 (en) | 2017-09-13 |
US9309493B2 (en) | 2016-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL215239A0 (en) | Salmonella enterica presenting c.jejuni n-glycan or derivatives thereof | |
AP2012006216A0 (en) | Benzimidazole-imidazole derivatives. | |
ZA201205788B (en) | 1,2,4-triazine-4-amine derivatives | |
IL219694A0 (en) | Sweetener and method for the production thereof | |
AP2011005821A0 (en) | Processing biomas. | |
BRPI0906394A2 (pt) | Maca | |
ZA200904060B (en) | Salmonella vaccine | |
GB2520450B (en) | Over-speed detection system | |
EP2464363A4 (en) | NATURAL EXTRACT FROM WHOLE BANANAS (MUSA SPP.) | |
EP2446755A4 (en) | STERILIZER FOR FOOD | |
DK2639234T3 (da) | Krystallinsk 6,7-umættet 7-carbamoylmorphinanderivat og fremgangsmåde til fremstilling heraf | |
ZA200906132B (en) | Improved disinfestation method | |
PL2400862T3 (pl) | Sposób utrwalania artykułów spożywczych | |
GB0910464D0 (en) | Indicator, application thereof and related products | |
AP2012006340A0 (en) | Turbine. | |
SI2513119T1 (sl) | 3,4,4a,10b-tetrahidro-1H-tiopirano-(4,3-c)izokinolinski derivati | |
EP2402744A4 (en) | AUFKOHLUNGSERKENNUNGSVERFAHREN | |
MY165626A (en) | 1,2,4,-triazolone derivative | |
EP2263475A4 (en) | FOODS WITH LOW PROTEIN COMPONENT AND MANUFACTURING METHOD THEREFOR | |
EP2284283A4 (en) | METHODS AND REAGENTS FOR DETECTION OF SALMONELLA SP. | |
EP2387417A4 (en) | BROAD SPECTRUM VACCINE AGAINST NON-TYPHOID SALMONELLA | |
GB201117793D0 (en) | Locking penetrator | |
AP2011005885A0 (en) | Flavanoid compounds and process for preparation thereof. | |
ZA201101786B (en) | Non-typhoidal salmonella vaccines | |
EP2457921A4 (en) | AUREOLIC ACID DERIVATIVES, PROCESS FOR OBTAINING THEM AND USES THEREOF |